Keliximab (anti-CD4)
|
Ab191955-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
174722-30-6 |
1mg
|
¥ 2859.9
|
期货,请咨询 |
阿拉丁 |
Keliximab (anti-CD4)
|
Ab191955-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
174722-30-6 |
10mg
|
¥ 11399.9
|
期货,请咨询 |
阿拉丁 |
Keliximab (anti-CD4)
|
Ab191955-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
174722-30-6 |
100μg
|
¥ 579.9
|
期货,请咨询 |
阿拉丁 |
Stamulumab (anti-Myostatin)
|
Ab191951-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
705287-60-1 |
5mg
|
¥ 5299.9
|
期货,请咨询 |
阿拉丁 |
Stamulumab (anti-Myostatin)
|
Ab191951-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
705287-60-1 |
1mg
|
¥ 2059.9
|
期货,请咨询 |
阿拉丁 |
Stamulumab (anti-Myostatin)
|
Ab191951-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
705287-60-1 |
10mg
|
¥ 8499.9
|
期货,请咨询 |
阿拉丁 |
Stamulumab (anti-Myostatin)
|
Ab191951-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
705287-60-1 |
100μg
|
¥ 419.9
|
期货,请咨询 |
阿拉丁 |
Fsn0503h (anti-Cathepsin S)
|
Ab191933-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Fsn0503h (anti-Cathepsin S)
|
Ab191933-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Fsn0503h (anti-Cathepsin S)
|
Ab191933-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Fsn0503h (anti-Cathepsin S)
|
Ab191933-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Lendalizumab (anti-Complement C5)
|
Ab191930-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2210314-30-8 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Lendalizumab (anti-Complement C5)
|
Ab191930-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2210314-30-8 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Lendalizumab (anti-Complement C5)
|
Ab191930-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2210314-30-8 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Lendalizumab (anti-Complement C5)
|
Ab191930-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2210314-30-8 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
AB1-11 (anti-CLDN6)
|
Ab191929-5mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
AB1-11 (anti-CLDN6)
|
Ab191929-1mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
AB1-11 (anti-CLDN6)
|
Ab191929-10mg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
AB1-11 (anti-CLDN6)
|
Ab191929-100μg
|
ExactAb™, 已验证, 无载体, 重组, Azide Free, 低内毒素, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Ebronucimab (anti-PCSK9)
|
Ab191923-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2304800-90-4 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Ebronucimab (anti-PCSK9)
|
Ab191923-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2304800-90-4 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Ebronucimab (anti-PCSK9)
|
Ab191923-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2304800-90-4 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Ebronucimab (anti-PCSK9)
|
Ab191923-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2304800-90-4 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
APX-007 (anti-IL-6Ra)
|
Ab191916-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |